Advertisement

PharmacoEconomics & Outcomes News

, Volume 842, Issue 1, pp 19–19 | Cite as

Neuropad for diagnosis of diabetic peripheral neuropathy cost saving

Clinical study
  • 3 Downloads

Reference

  1. Rodriguez-Sanchez B, et al. Cost-effectiveness analysis of the Neuropad device as a screening tool for early diabetic peripheral neuropathy. European Journal of Health Economics : 12 Nov 2019. Available from: URL: https://doi.org/10.1007/s10198-019-01134-2

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations